A putative Fgf23 bone enhancer, located in an Fgf23 intron, was targeted with sgRNAs (targeting TGTCTCTATTATCTGCAGGG and AAACACAAGAAGTTGAGGGC) using CRISPR/Cas9 technology, resulting in a 296 bp deletion. (J:281531)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count